Drug Database
Back to search

Japan· JP-1290402G3029

ジフェリケファリン酢酸塩

A difelikefalin product containing ジフェリケファリン酢酸塩, registered in Japan by 丸石製薬, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

On Japan’s NHI price listATC V03AX04

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedジフェリケファリン酢酸塩ATCV03AX04REGISTER NO.JP-1290402G3029PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ジフェリケファリン酢酸塩Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Difelikefalin is registered in 14 of 19 countries.

Countries holding a registration under ATC V03AX04 (difelikefalin), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 9 of them publish a price we can compare per daily dose
Search difelikefalin products by name

Difelikefalin · ATC V03AX04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ジフェリケファリン酢酸塩
Manufacturer
丸石製薬
Country
Japan (JP)
ATC code
V03AX04
ATC class
Difelikefalin
Defined daily dose
15 mcg, P
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V03AX04

Difelikefalin, as other registers publish it.

All difelikefalin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dd487a85-4e52-46ea-b1de-d286447d4bf9
GET /v1/drugs/dd487a85-4e52-46ea-b1de-d286447d4bf9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "３５μｇ０．７ｍＬ１筒",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "1290402G3029",
  "category": "注射薬",
  "price_yen": 4341,
  "generic_name": "ジフェリケファリン酢酸塩",
  "product_name_jp": null,
  "therapeutic_class": "1290",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about difelikefalin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console